Originally developed to lower blood glucose levels in diabetic patients, several clinical trials have firmly established that SGLT2i is also beneficial for patients living with HFpEF 2
Important: Never double the dose
In preclinical animal models of gastric cancer, pancreatic cancer, renal cancer, and several other common malignancies, the product also displayed consistent favorable tumorsuppressive pharmacological effects
Glutathione, Accessed April 4, 2021 Leukotrienes, Accessed April 4, 2021 Melanin (Compound), Accessed April 4, 2021 Skin lightening, Accessed April 4, 2021 Melanin, Accessed April 4, 2021 Intravenous glutathione for skin lightening: inadequate safety data, Accessed April 4, 2021 Glutathione as a skin whitening agent: Facts, myths, evidence and controversies, Accessed April 4, 2021 The role of systemic treatments for skin lightening, Accessed April 4, 2021 Current Version 09/01/2022 Written by Louise Nichole Logarta Medically reviewed by Angeli Eloise E
PMID 11689711